Teachers Advisors’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Teachers Advisors’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-54,353	Closed	-$79K	–	3179
2018 Q1	$79K	Hold	54,353	–	–	﹤0.01%	2952
2017 Q4	$122K	Buy	54,353 +3,572	+7%	+$9.04K	﹤0.01%	2991
2017 Q3	$173K	Sell	50,781 -7,247	-12%	-$24.4K	﹤0.01%	2992
2017 Q2	$206K	Buy	58,028 +6,714	+13%	+$22.1K	﹤0.01%	3003
2017 Q1	$174K	Buy	51,314 +329	+0.6%	+$1.28K	﹤0.01%	2900
2016 Q4	$235K	Buy	50,985 +27,724	+119%	+$114K	﹤0.01%	2859
2016 Q3	$99K	Sell	23,261 -1,695	-7%	-$5.48K	﹤0.01%	3006
2016 Q2	$60K	Buy	24,956 +10,323	+71%	+$37.3K	﹤0.01%	3071
2016 Q1	$69K	Hold	14,633	–	–	﹤0.01%	2989
2015 Q4	$58K	Hold	14,633	–	–	﹤0.01%	3061
2015 Q3	$57K	Sell	14,633 -11	-0.1%	-$51	﹤0.01%	3058
2015 Q2	$67K	Buy	+14,644	New	+$140K	﹤0.01%	3068

Other funds holding AST

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Teachers Advisors's AST Position: Q2 2018 in Review

Teachers Advisors sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q2 2018, closing a stake of 54,353 shares — an estimated $79K sold.

Teachers Advisors first reported a position in AST in Q2 2015 and held it in 12 quarters. The position peaked at $235K in Q4 2016. 62 funds tracked by Wall St. Rank hold AST as of Q2 2018.

Teachers Advisors reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q2 2018 after selling out during the quarter.
Teachers Advisors sold 54,353 Asterias Biotherapeutics Inc. Series A shares in Q2 2018, an estimated $79K.
Teachers Advisors first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2015 and held it in 12 quarters.
Teachers Advisors's Asterias Biotherapeutics Inc. Series A position peaked at $235K in Q4 2016.
62 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q2 2018.

Based on Teachers Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.